Proteome characterization of XPC-deficient melanocytes generated by CRISPR-Cas9 technology reveals alteration in the expression of several hundred proteins

J Dermatol Sci. 2024 Mar 23:S0923-1811(24)00052-5. doi: 10.1016/j.jdermsci.2024.03.006. Online ahead of print.

¹ Univ. Bordeaux, Inserm, BRIC, Bordeaux, France; Aquiderm, University of Bordeaux, Bordeaux, France.
² NAOS Institute of Life Science, Aix-en-Provence, France.
³ Univ. Bordeaux, Inserm, BRIC, Bordeaux, France.
⁴ Univ. Bordeaux, Bordeaux Proteome, Bordeaux, France.
⁵ Nucleic Acids Lesions Laboratory, SCIB/INAC, CEA, Universite´ Joseph Fourier- Grenoble, Grenoble, France.
⁶ Univ. Bordeaux, Inserm, BRIC, Bordeaux, France; Paediatric Dermatology Department, Bordeaux University Hospital, Bordeaux, France.
⁷ Univ. Bordeaux, Inserm, BRIC, Bordeaux, France; Aquiderm, University of Bordeaux, Bordeaux, France. Electronic address: hamid-reza.rezvani@u-bordeaux.fr.

No abstract available

Publication types